Cargando…

Reproducibility and Predictive Value of White-Coat Hypertension in Young to Middle-Age Subjects

(1) Aim. The aim of the study was to investigate the reproducibility of white-coat hypertension (WCH) and its predictive capacity for hypertension needing antihypertensive treatment (HT) in young to middle-age subjects. (2) Methods. We investigated 1096 subjects from the HARVEST. Office and 24 h blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palatini, Paolo, Mos, Lucio, Saladini, Francesca, Vriz, Olga, Fania, Claudio, Ermolao, Andrea, Battista, Francesca, Rattazzi, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914311/ https://www.ncbi.nlm.nih.gov/pubmed/36766538 http://dx.doi.org/10.3390/diagnostics13030434

Ejemplares similares

Both Moderate and Heavy Alcohol Use Amplify the Adverse Cardiovascular Effects of Smoking in Young Patients with Hypertension
por: Palatini, Paolo, et al.
Publicado: (2023)

Exaggerated blood pressure response to standing in young-to-middle-age subjects: prevalence and factors involved
por: Palatini, Paolo, et al.
Publicado: (2023)

Leisure-Time Physical Activity Has a More Favourable Impact on Carotid Artery Stiffness Than Vigorous Physical Activity in Hypertensive Human Beings
por: Vriz, Olga, et al.
Publicado: (2022)

White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
por: Bursztyn, Michael, et al.
Publicado: (2009)

Carcinoid Heart Disease: Starting From Heart Failure
por: Bertin, Nicole, et al.
Publicado: (2017)

White coat hypertension in pediatrics
por: Jurko, Alexander, et al.
Publicado: (2016)

Decoding white coat hypertension
por: Bloomfield, Dennis A, et al.
Publicado: (2017)

Prediction of white-coat hypertension and white-coat uncontrolled hypertension using machine learning algorithm
por: Shih, Ling-Chieh, et al.
Publicado: (2022)

In-hospital and long-term mortality in Takotsubo cardiomyopathy: a community hospital experience
por: Vriz, Olga, et al.
Publicado: (2016)

Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension
por: Palatini, Paolo, et al.
Publicado: (2011)

White-Coat Hypertension: the Neglected Subgroup in Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2018)

Orthostatic Hypertension: A Newcomer Among the Hypertension Phenotypes
por: Palatini, Paolo
Publicado: (2023)

Targeting White Coat Hypertension: Is the Daytime Enough?
por: Cuspidi, Cesare, et al.
Publicado: (2020)

Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA
por: Barroso, Weimar Kunz Sebba, et al.
Publicado: (2019)

American Versus European Hypertension Guidelines: The Case of White Coat Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2020)

Complications of White-coat Hypertension Compared to a Normotensive and Hypertensive Population
por: Taher, Ziad Abdullah, et al.
Publicado: (2021)

Should White-Coat Hypertension in Diabetes Be Treated? Pro
por: Mancia, Giuseppe, et al.
Publicado: (2009)

The impact of protein oxidation on sustained and white coat hypertension
por: Yıldırım, Erkan, et al.
Publicado: (2017)

Current status of white coat hypertension: where are we?
por: Nuredini, Gani, et al.
Publicado: (2020)

Blood Pressure Variability and Therapeutic Implications in Hypertension and Cardiovascular Diseases
por: Nardin, Chiara, et al.
Publicado: (2019)

Correspondence regarding “Ventilatory efficiency in athletes, asthma and obesity”: different ventilatory phenotypes during exercise in obesity?
por: Borasio, Nicola, et al.
Publicado: (2022)

The differential diagnostic value of serum homocysteine for white coat hypertension
por: Guo, Shitian, et al.
Publicado: (2017)

Differential Expression of Hypertension-Associated MicroRNAs in the Plasma of Patients With White Coat Hypertension
por: Cengiz, Mahir, et al.
Publicado: (2015)

White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Establishment of a scoring model for the differential diagnosis of white coat hypertension and sustained hypertension
por: Cai, Peng, et al.
Publicado: (2023)

Prevalence, Predictive Factor, and Clinical Significance of White-Coat Hypertension and Masked Hypertension in Korean Hypertensive patients
por: Hwang, Eui-Seock, et al.
Publicado: (2007)

The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study
por: Satoh, Michihiro, et al.
Publicado: (2023)

Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population
por: Johansson, Martina A.K., et al.
Publicado: (2021)

Impact of White-Coat Hypertension on Microvascular Complications in Type 2 Diabetes
por: Kramer, Caroline K., et al.
Publicado: (2008)

Epidemiology of Masked and White-Coat Hypertension: The Family-Based SKIPOGH Study
por: Alwan, Heba, et al.
Publicado: (2014)

White coat hypertension: improving the patient–health care practitioner relationship
por: Cobos, Briana, et al.
Publicado: (2015)

Effect of white-coat hypertension on arterial stiffness: A meta-analysis
por: Cai, Peng, et al.
Publicado: (2018)

White Coat Uncontrolled Hypertension in Teleconsultation: A New and Frequent Entity
por: Barochiner, Jessica, et al.
Publicado: (2021)

White coat hypertension during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

I Brazilian Position Paper on Prehypertension, White Coat Hypertension and Masked Hypertension: Diagnosis and Management
por: Alessi, Alexandre, et al.
Publicado: (2014)

Association of parathyroid hormone and vitamin D with untreated hypertension: Is it different in white-coat or sustained hypertension?
por: Akgül, Ferit, et al.
Publicado: (2017)

Evaluation of left ventricular function in overweight children and teenagers with arterial hypertension and white coat hypertension
por: Floriańczyk, Tomasz, et al.
Publicado: (2019)

Prevalence and Related Factors of White Coat Hypertension and Masked Hypertension in Shunde District, Southern China
por: Zhu, Hailan, et al.
Publicado: (2022)

Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension
por: Shehab, Abdullah, et al.
Publicado: (2011)

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality
por: Huang, Yuli, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dcidvo2iaq3820kn5neknskkte